云顶集团3118(中国)

    An overview of growth factors as the potential link between psoriasis and metabolic syndrome.

    Mateusz Matwiejuk, Adrian Chabowski, Iwona Flisiak, Hanna Myśliwiec

    Published: 2023-11-02 DOI: 10.17504/protocols.io.6qpvr3rwzvmk/v1
    AI 解读
    浏览 1421

    Abstract

    Psoriasis

    is a chronic, complex, immunologically mediated, systematic disease that can

    not only affect the skin but also the joints, and nails. It may coexist with

    various other disorders such as depression, psoriatic arthritis, cardiovascular

    diseases, diabetes mellitus, and metabolic syndrome. In particular, the

    potential link between psoriasis and metabolic syndrome is worthy of an

    attention issue. A dysregulated level of growth factors could potentially

    contribute to the disturbances of keratinocyte proliferation, inflammation, and

    severity of itch. However, the

    pathophysiology of psoriasis and its comorbidities, such as metabolic syndrome,

    remain incompletely elucidated. Growth factors and their abnormal metabolism may

    be the potential link connecting this conditions. Overall, the objective of

    this review is to analyze the role of growth factors disturbances in psoriasis

    and in metabolic syndrome.

    Attachments

    GF PRISMA_2020_checklist.docx References.docx Methodological approach.docx

    Steps

    1.

    Identification of records. Databases (n = 1) Pubmed

    2.

    Screening of records

    Records screened (n = 1579)

    3.

    Records excluded (n = 1372 )

    No data available

    Abstracts

    4.

    Reports assesed for eligibility (n = 207 )

    5.

    Reports excluded

    Reason 1 (n = 38 ) Duplications

    Reason 2 (n = 77 ) Out of scope

    6.

    Studies included in review (n = 92 )

    9.

    Records

    identified

    推荐阅读

    Nature Protocols
    Protocols IO
    Current Protocols
    扫码咨询